ASSESSMENT OF THE RESIDUAL TUMOR IN PATIENTS WITH MULTIPLE MYELOMA BASED ON THE ANALYSIS OF THE FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN BLOOD SERUM

Alʹmanah Kliničeskoj Mediciny. 2016;0(29):33-37 DOI 10.18786/2072-0505-2013-29-33-37

 

Journal Homepage

Journal Title: Alʹmanah Kliničeskoj Mediciny

ISSN: 2072-0505 (Print); 2587-9294 (Online)

Publisher: MONIKI

Society/Institution: MONIKI

LCC Subject Category: Medicine

Country of publisher: Russian Federation

Language of fulltext: Russian

Full-text formats available: PDF

 

AUTHORS

T. A. Мitina (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
A. K. Golenkov (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
A. Yu. Baryshnikov (Russian Oncologic Research Center n.a. N.N. Blokhin, RAMS RF, Moscow)
A. V. Karaulov (First Moscow State Medical University n.a. I.M. Sechenov)
E. V. Trifonova (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
Yu. B. Chernykh (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
E. V. Katayeva (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
T. D. Lutskaya (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
L. L. Vysotskaya (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
G. A. Dudina (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
S. G. Zacharov (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
A. M. Fomin (M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
N. V. Lyubimova (Russian Oncologic Research Center n.a. N.N. Blokhin, RAMS RF, Moscow)
I. N. Kogarko (Research Institute of Chemical Physics n.a. N.N. Semionov, RAS, Moscow)

EDITORIAL INFORMATION

Peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 8 weeks

 

Abstract | Full Text

Efficiency of the multiple myeloma treatment with chemotherapy including bortezomib was assessed based on determination of the level of immunoglobulin free light chains in blood serum. The method enables estimation of changes in kinetic parameters of the residual tumor, detection of the disease course prognosis, and the choice of the optimal approach to the disease therapy.